FYDASQ Trademark

Trademark Overview

On Tuesday, October 10, 2017, a trademark application was filed for FYDASQ with the United States Patent and Trademark Office. The USPTO has given the FYDASQ trademark a serial number of 87639468. The federal status of this trademark filing is REGISTERED as of Tuesday, August 10, 2021. This trademark is owned by Gilead Sciences Ireland UC. The FYDASQ trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis
fydasq

General Information

Serial Number87639468
Word MarkFYDASQ
Filing DateTuesday, October 10, 2017
Status700 - REGISTERED
Status DateTuesday, August 10, 2021
Registration Number6443782
Registration DateTuesday, August 10, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 19, 2018

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 17, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, August 10, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, July 8, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, June 21, 2021NOTICE OF ALLOWANCE CANCELLED
Monday, June 21, 2021TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021EXTENSION 5 GRANTED
Thursday, December 17, 2020EXTENSION 5 FILED
Monday, January 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 17, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020EXTENSION 4 GRANTED
Wednesday, June 17, 2020EXTENSION 4 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Saturday, December 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2019EXTENSION 3 GRANTED
Thursday, December 19, 2019EXTENSION 3 FILED
Thursday, December 19, 2019TEAS EXTENSION RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2019EXTENSION 2 GRANTED
Monday, June 17, 2019EXTENSION 2 FILED
Monday, June 17, 2019TEAS EXTENSION RECEIVED
Thursday, December 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 11, 2018EXTENSION 1 GRANTED
Tuesday, December 11, 2018EXTENSION 1 FILED
Tuesday, December 11, 2018TEAS EXTENSION RECEIVED
Tuesday, August 14, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 19, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 30, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 11, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 1, 2018ASSIGNED TO LIE
Tuesday, April 24, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 19, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 19, 2018LETTER OF SUSPENSION E-MAILED
Friday, January 19, 2018SUSPENSION LETTER WRITTEN
Friday, January 19, 2018ASSIGNED TO EXAMINER
Tuesday, October 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

fydasq pharmaceutical preparations treatment diseases disorders anti inflammatory respiratory kidney arthritis